- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1682-4016
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Programmed death-ligand 1 expression in rectal cancer ; day:7 ; month:10 ; year:2016 ; pages:1-5
European surgery ; (7.10.2016), 1-5
- Urheber
-
Jomrich, G.
- Beteiligte Personen und Organisationen
- DOI
-
10.1007/s10353-016-0447-8
- URN
-
urn:nbn:de:1111-2016110725575
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jomrich, G.
- Silberhumer, G. R.
- Marian, B.
- Beer, A.
- Müllauer, Leonhard
- SpringerLink (Online service)
Ähnliche Objekte (12)
Status of programmed death-ligand 1 expression in sarcomas
Programmed death-ligand 1 expression in carcinoma of unknown primary
Programmed death-ligand 1 (PD-L1) expression in various tumor types
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study
Programmed death‐ligand 1 expression in Epstein‐Barr virus positive nasopharyngeal cancer
Programmed death-ligand 1 and mammalian target of rapamycin signaling pathway in locally advanced rectal cancer
Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma
Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme
Programmed death-ligand 1 expression and overall survival in Thai patients with gastric cancer
Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma
Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases
Status of programmed death-ligand 1 expression in sarcomas
Programmed death-ligand 1 expression in carcinoma of unknown primary
Programmed death-ligand 1 (PD-L1) expression in various tumor types
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study
Programmed death‐ligand 1 expression in Epstein‐Barr virus positive nasopharyngeal cancer
Programmed death-ligand 1 and mammalian target of rapamycin signaling pathway in locally advanced rectal cancer
Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma
Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme
Programmed death-ligand 1 expression and overall survival in Thai patients with gastric cancer
Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma
Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases
Status of programmed death-ligand 1 expression in sarcomas
Programmed death-ligand 1 expression in carcinoma of unknown primary
Programmed death-ligand 1 (PD-L1) expression in various tumor types
Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study
Programmed death‐ligand 1 expression in Epstein‐Barr virus positive nasopharyngeal cancer
Programmed death-ligand 1 and mammalian target of rapamycin signaling pathway in locally advanced rectal cancer
Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma
Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme
Programmed death-ligand 1 expression and overall survival in Thai patients with gastric cancer
Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma